vs

Side-by-side financial comparison of Caesars Entertainment (CZR) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.

Caesars Entertainment is the larger business by last-quarter revenue ($2.9B vs $1.5B, roughly 1.9× BeOne Medicines Ltd.). BeOne Medicines Ltd. runs the higher net margin — 4.4% vs -2.9%, a 7.3% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 2.7%). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 0.7%).

Caesars Entertainment, Inc., formerly Eldorado Resorts, Inc., is an American hotel and casino entertainment company founded and based in Reno, Nevada, that operates more than 50 properties. Eldorado Resorts acquired Caesars Entertainment Corporation and changed its own name to Caesars Entertainment on July 20, 2020.

BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.

CZR vs ONC — Head-to-Head

Bigger by revenue
CZR
CZR
1.9× larger
CZR
$2.9B
$1.5B
ONC
Growing faster (revenue YoY)
ONC
ONC
+30.1% gap
ONC
32.8%
2.7%
CZR
Higher net margin
ONC
ONC
7.3% more per $
ONC
4.4%
-2.9%
CZR
Faster 2-yr revenue CAGR
ONC
ONC
Annualised
ONC
41.2%
0.7%
CZR

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CZR
CZR
ONC
ONC
Revenue
$2.9B
$1.5B
Net Profit
$-83.0M
$66.5M
Gross Margin
90.5%
Operating Margin
17.4%
12.4%
Net Margin
-2.9%
4.4%
Revenue YoY
2.7%
32.8%
Net Profit YoY
15.3%
143.8%
EPS (diluted)
$-0.48
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CZR
CZR
ONC
ONC
Q1 26
$2.9B
Q4 25
$2.9B
$1.5B
Q3 25
$2.9B
$1.4B
Q2 25
$2.9B
$1.3B
Q1 25
$2.8B
$1.1B
Q4 24
$2.8B
$1.1B
Q3 24
$2.9B
$1.0B
Q2 24
$2.8B
$929.2M
Net Profit
CZR
CZR
ONC
ONC
Q1 26
$-83.0M
Q4 25
$-250.0M
$66.5M
Q3 25
$-55.0M
$124.8M
Q2 25
$-82.0M
$94.3M
Q1 25
$-115.0M
$1.3M
Q4 24
$11.0M
$-151.9M
Q3 24
$-9.0M
$-121.3M
Q2 24
$-122.0M
$-120.4M
Gross Margin
CZR
CZR
ONC
ONC
Q1 26
Q4 25
90.5%
Q3 25
86.1%
Q2 25
87.5%
Q1 25
85.2%
Q4 24
85.8%
Q3 24
83.0%
Q2 24
85.1%
Operating Margin
CZR
CZR
ONC
ONC
Q1 26
17.4%
Q4 25
11.4%
12.4%
Q3 25
17.9%
11.5%
Q2 25
18.1%
6.7%
Q1 25
17.5%
1.0%
Q4 24
23.9%
-7.0%
Q3 24
22.4%
-12.0%
Q2 24
17.9%
-11.5%
Net Margin
CZR
CZR
ONC
ONC
Q1 26
-2.9%
Q4 25
-8.6%
4.4%
Q3 25
-1.9%
8.8%
Q2 25
-2.8%
7.2%
Q1 25
-4.1%
0.1%
Q4 24
0.4%
-13.5%
Q3 24
-0.3%
-12.1%
Q2 24
-4.3%
-13.0%
EPS (diluted)
CZR
CZR
ONC
ONC
Q1 26
$-0.48
Q4 25
$-1.22
$0.05
Q3 25
$-0.27
$0.08
Q2 25
$-0.39
$0.06
Q1 25
$-0.54
$0.00
Q4 24
$0.04
$-0.10
Q3 24
$-0.04
$-0.09
Q2 24
$-0.56
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CZR
CZR
ONC
ONC
Cash + ST InvestmentsLiquidity on hand
$867.0M
$4.5B
Total DebtLower is stronger
$836.4M
Stockholders' EquityBook value
$4.4B
Total Assets
$8.2B
Debt / EquityLower = less leverage
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CZR
CZR
ONC
ONC
Q1 26
$867.0M
Q4 25
$887.0M
$4.5B
Q3 25
$836.0M
$4.0B
Q2 25
$982.0M
$2.8B
Q1 25
$884.0M
$2.5B
Q4 24
$866.0M
$2.6B
Q3 24
$802.0M
$2.7B
Q2 24
$830.0M
$2.6B
Total Debt
CZR
CZR
ONC
ONC
Q1 26
Q4 25
$11.9B
$836.4M
Q3 25
$11.9B
Q2 25
$12.3B
Q1 25
$12.3B
Q4 24
$12.3B
Q3 24
$12.7B
Q2 24
$12.4B
Stockholders' Equity
CZR
CZR
ONC
ONC
Q1 26
Q4 25
$3.5B
$4.4B
Q3 25
$3.8B
$4.1B
Q2 25
$3.9B
$3.8B
Q1 25
$4.1B
$3.5B
Q4 24
$4.2B
$3.3B
Q3 24
$4.2B
$3.4B
Q2 24
$4.3B
$3.4B
Total Assets
CZR
CZR
ONC
ONC
Q1 26
Q4 25
$31.6B
$8.2B
Q3 25
$31.9B
$7.6B
Q2 25
$32.5B
$6.3B
Q1 25
$32.4B
$5.8B
Q4 24
$32.6B
$5.9B
Q3 24
$33.0B
$5.8B
Q2 24
$33.1B
$5.7B
Debt / Equity
CZR
CZR
ONC
ONC
Q1 26
Q4 25
3.40×
0.19×
Q3 25
3.15×
Q2 25
3.15×
Q1 25
3.04×
Q4 24
2.96×
Q3 24
3.04×
Q2 24
2.89×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CZR
CZR
ONC
ONC
Operating Cash FlowLast quarter
$417.3M
Free Cash FlowOCF − Capex
$379.8M
FCF MarginFCF / Revenue
25.4%
Capex IntensityCapex / Revenue
2.5%
Cash ConversionOCF / Net Profit
6.28×
TTM Free Cash FlowTrailing 4 quarters
$941.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CZR
CZR
ONC
ONC
Q1 26
Q4 25
$304.0M
$417.3M
Q3 25
$318.0M
$402.6M
Q2 25
$462.0M
$263.6M
Q1 25
$218.0M
$44.1M
Q4 24
$309.0M
$75.2M
Q3 24
$232.0M
$188.4M
Q2 24
$454.0M
$-95.6M
Free Cash Flow
CZR
CZR
ONC
ONC
Q1 26
Q4 25
$147.0M
$379.8M
Q3 25
$123.0M
$354.5M
Q2 25
$232.0M
$219.8M
Q1 25
$-5.0M
$-12.3M
Q4 24
$30.0M
$-17.3M
Q3 24
$-192.0M
$54.7M
Q2 24
$125.0M
$-205.5M
FCF Margin
CZR
CZR
ONC
ONC
Q1 26
Q4 25
5.0%
25.4%
Q3 25
4.3%
25.1%
Q2 25
8.0%
16.7%
Q1 25
-0.2%
-1.1%
Q4 24
1.1%
-1.5%
Q3 24
-6.7%
5.5%
Q2 24
4.4%
-22.1%
Capex Intensity
CZR
CZR
ONC
ONC
Q1 26
Q4 25
5.4%
2.5%
Q3 25
6.8%
3.4%
Q2 25
7.9%
3.3%
Q1 25
8.0%
5.0%
Q4 24
10.0%
8.2%
Q3 24
14.8%
13.3%
Q2 24
11.6%
11.8%
Cash Conversion
CZR
CZR
ONC
ONC
Q1 26
Q4 25
6.28×
Q3 25
3.22×
Q2 25
2.79×
Q1 25
34.71×
Q4 24
28.09×
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CZR
CZR

Casino$1.7B58%
Hotel$487.0M17%
Food and beverage$424.0M15%
Other$293.0M10%

ONC
ONC

Segment breakdown not available.

Related Comparisons